Evaluation of in-house and commercial genotyping assays for molecular typing of hepatitis C virus in Hong Kong

British Journal of Biomedical Science

Volumn 67, Issue 2, 2010, Pages 82-85

  Lam, T H J ^a   Cheng, P S ^a   Lai, S T ^b   Tsang, T Y ^b   Cheng, V C C ^a   Ho, S L ^a   Yam, W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Genotype; Hepatitis C; Hybridization, genetic; Polymerase chain reaction

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; EVALUATION; FALSE NEGATIVE RESULT; GENOTYPE; HEPATITIS C VIRUS; HONG KONG; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS ISOLATION;

HEPATITIS C VIRUS;

EID: 77954304391     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2010.11730296     Document Type: Article

References (23)

1. World Health Organization. Hepatitis C. Factsheet No. 164, 2000 (www.who.inf/mediacentre/factsheets/fs164/en/index.html).
2. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 1995; 122: 161-8.
3. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125: 634-9.
4. McHutchison JG, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339: 1485-92.
5. Arens M. Clinically relevant sequence-based genotyping of HBV, HCV, CMV and HIV. J Clin Virol 2001; 22: 11-29.
6. Ohno T, Mizokami M, Wu RR et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a and 6a. J Clin Microbiol 1997; 35: 201-7.
7. Dogic V, Bingulac-Popovic J, Babic I et al. Mistyped HCV genotype results of external quality control - requirement for introduction of an improved method: P2 (Abstract, Seventh International Symposium on Molecular Diagnostics, Graz, Austria) Clin Chem Lab Med 2008; 46: A56 (www.reference-global.com/doi/ pdf/10.1515/CCLM.2008.055).
8. El Sharkawi FZ, Chudy M, Hanschmann KM, Kress J, Nübling CM. Consistency of quantitation of HCV genotype 4 from Egypt across three HCV-RNA amplification assays. J Med Virol 2008; 80: 2086-91.
9. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13: 223-35.
10. Martro E, Gonzalez V, Buckton AJ et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5′ noncoding and nonstructural 5b genomic regions. J Clin Microbiol 2008; 46: 192-7.
11. McOmish F, Yap PL, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884-92.
12. Zhang YY, Lok AS, Chan DT, Widell A. Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China. J Clin Microbiol 1995; 33: 2931-4.
13. Corbet S, Bukh J, Heinsen A, Fomsgaard A. Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 2003; 41: 1091-100.
14. Tokita H, Okamoto H, Tsuda F et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 11022-6.
15. Mellor J, Walsh EA, Prescott LE et al. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 1996; 34: 417-23.
16. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995; 76 (10): 2493-507.
17. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995; 345: 1211-3.
18. Bronowicki JP, Venard V, Botte C et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337: 237-40. (Pubitemid 27310439)
19. Prescott LE, Simmonds P, Lai CL et al. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J Med Virol 1996; 50: 168-75.
20. Wong DA, Tong LK, Lim W. High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong. Eur J Epidemiol 1998; 14: 421-6. (Pubitemid 28370776)
21. Zhou DX, Tang JW, Chu IM et al. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 2006; 78: 574-81.
22. Yuen MF, Lai CL. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong. Intervirology 2006; 49: 96-8.
23. Maertens G, Lieven S. HCV genotyping by the line probe assay INNO-LiPA HCV II. In: Lau JY ed. Hepatitis C protocols. Totowa NJ: Humana Press, 1998: 183-98.